Vitiligo Treatment Market Research Report Information by Type (Segmental Vitiligo, Non-Segmental Vitiligo), By Treatment (Therapy, Surgery, Medication), By End-User (Hospitals, Ambulatory Clinics, Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2030
Over the course of the forecast period, the Vitiligo Treatment Market industry is expected to grow at a compound annual growth rate (CAGR) of 6.20%. The market is expanding due to factors such the rising prevalence of vitligo, the growing significance of aesthetic appeal and awareness, and improvements in treatment choices.
Consumers' understanding of various cosmetic treatments, rising per capita income, and the use of digital platforms have all contributed to a notable increase in beauty consciousness in recent years. As to the report by the International Society of Aesthetic Plastic Surgery (ISAPS), the global total non-surgical procedures grew by 27.3% between 2015 and 2019. Furthermore, the American Society of Plastic Surgeons (ASPS) reports that between 2000 and 2017, the number of minimally invasive cosmetic operations increased by around 200%. Furthermore, in 2018, 15.9 million minimally invasive cosmetic treatments were carried out, a 2% increase from the previous year.
Insights on Market SegmentsSegmental and non-segmental vitiligo are included in the market segmentation for vitiligo treatments depending on kind.
Therapy, surgery, and medication are the three types of treatments that form the basis of market segmentation.
Hospitals, ambulatory clinics, and other end users are included in the market segmentation based on end-user.
Regional PerspectivesIn terms of market share in 2023, the North American vitiligo treatment market held the most share. because of the sophisticated healthcare system and growing public awareness of skin conditions. Because of the region's significant emphasis on research and development, novel treatments such as biologics, topical medicines, and enhanced phototherapy have been introduced.
The market for vitiligo treatment in Europe is anticipated to hold the second-largest share owing to the trend of integrating vitiligo treatment and favorable health policies. Furthermore, it was reported that the French vitiligo treatment market will develop at the highest rate in the European Union, while the German vitiligo treatment market held the biggest market share.
The market for vitiligo treatments in Asia-Pacific is anticipated to expand at the fastest rate between 2024 and 2032. This is because increased healthcare spending and improved healthcare infrastructure have made innovative therapies more accessible. Other important causes include the increasing incidence of vitiligo and the increased need for dermatological and cosmetic therapies.
Africa, Latin America, and the Middle East make up the rest of the world. the primary causes driving the expansion of vitiligo treatments in Africa and the Middle East. The MEA area has seen Rising diagnosis rates and an increased need for efficient therapies are being caused by vitiligo's de-stigmatization and increased global awareness.
Principal PlayersStrata Skin Sciences (US), Incyte (US), Bausch Health Companies Inc. (Canada), Reddy's Laboratories Ltd. (India), Clinuvel Pharmaceuticals Ltd. (Australia), ISSAR Pharmaceuticals Pvt. Ltd. (India), Kernel Medical Equipment CO., LTD. (China), LightSources (US), and Roivant Sciences Ltd. (Switzerland) are some of the prominent companies in the vitiligo treatment market.